Aptus Pharma Limited Share Price

Aptus Pharma Limited Share Price

BSE: 544529
|
Pharmaceuticals
|
S Cap
₹ 314.20
+₹6.15 (2.00%)
1D
Last updated 03 Sep, 2026, 11:15 IST

Aptus Pharma Limited Share Price Today

As of 3 Sep 2026, Aptus Pharma Limited share price is ₹314.20. The stock opened at ₹314.20, compared to its previous close of ₹308.05. During today's trading session, Aptus Pharma Limited share price moved in the range of ₹314.20 to ₹314.20, with an average price of ₹314.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹32.32 and a high of ₹327.10.

₹314.20
2.00% up today
₹314.20
1D LOW
1D HIGH

Aptus Pharma Limited Returns Calculator

Circuit
L
H
₹301.90
₹314.20
52-week
L
H
₹32.32
₹327.10

About Aptus Pharma Limited

Aptus Pharma Limited Share Price
ISIN
INE15XJ01010
Sector Market Cap
₹ 528.31 Cr

Aptus Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing a range of medicine solutions which include Anti-Infectives, Antacids and PPI, G.I. Medicines, Anti-Allergic and Respiratory Medicine, Nutritional Supplements, Anti-Inflammatory and Pain Management, Neuro-Psychiatric Medicine, Lipid Lowering Medicine, Anti-Hypertensives and Cardiovascular Medicine, Antidiabetic Medicine, and Consumer Care. Its divisions include Aptus Pharma, Aptus CD Care, Aptus WellCare, and Aptus Global. Its brands include Chilkul, Koltus, Telbira, and Aptirub. Its products include APBILE-150, APBILE-300, APORA 5 CREAM, APTICHYM-FORTE, APTIDA-10, APTIDA-M, APTIDOL-MR, APTIDOX-L, APTIFRESH, APTIFRESH-EC, APTIFRESH-FM, APTIFRESH-LE, APTIFRESH-MD, APTIFRESH-MW, APTIGLIM-M1 FORTE, APTIGLIM-M1 PR, APTIGLIM-M2 FORTE, APTIGLIM-M2 SR, among others.

Aptus Pharma Limited Financial Highlights

  • Revenue: Aptus Pharma Limited reported revenue of ₹46.70 crore in FY26 vs ₹24.64 crore in FY25. It showed an increase of 89.53% on a yearly basis.
  • Operating Profit: Aptus Pharma Limited reported an operating profit of ₹6.37 crore in FY26 vs ₹4.20 crore in FY25. It showed an increase of 51.67% on a year-on-year basis.
  • Net Profit: Aptus Pharma Limited reported a net profit of ₹4.62 crore in FY26 vs ₹2.96 crore in FY25. It showed an increase of 56.08% on a yearly basis.
Know more
Promoters
72.89%
FII
0.00%
Other DII
0.00%
Retail and other
27.11%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
May 20260.00%
Jun 20260.00%
Mkt Cap Cr
528.31
P/E
51.88
P/B
22.63
ROE
19.79%
D/E
0.31
ROCE
23.50%
Div. Yield
0.00%
EPS(TTM)
7.78
Turnover
1.92
EV/EBITDA
32.41
Net Margin
9.92%
Op. Margin
16.28%
ROA
14.96%
Quick Ratio
1.12
Curr. Ratio
2.79
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Aptus Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Aptus Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Aptus Pharma Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹46.57₹24.56₹17.86₹13.90
Other Income₹0.13₹0.08₹0.03₹0.00
Total Revenue₹46.71₹24.64₹17.88₹13.90
Total Expenses₹40.33₹20.44₹16.76₹13.60
Profit Before Tax₹6.37₹4.20₹1.12₹0.30
Tax₹1.75₹1.10₹0.32₹0.10
Profit After Tax₹4.62₹3.10₹0.80₹0.19
EPS - Basic₹7.78₹6.37₹5.32₹1.30
EPS - Diluted₹7.78₹6.37₹5.32₹1.30

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹4.62₹3.10₹1.12₹0.30
Income before WC changes₹7.45₹4.85₹1.55₹0.62
Change in Assets-₹19.69-₹7.22-₹3.30-₹1.75
Change in Liabilities₹7.82₹1.64-₹0.08₹1.07
Change in WC-₹11.86-₹5.57-₹3.38-₹0.68
Cash flow from Operations-₹5.60-₹1.84-₹2.17-₹0.18
Cash flow from Investing-₹6.37-₹0.54-₹0.30-₹0.35
Cash flow from Financing₹7.79₹6.68₹2.86₹0.81
Total Cash Flow-₹4.19₹4.30₹0.38₹0.28
Cash (Start of the year)₹5.21₹0.91₹0.54₹0.26
Cash (End of the year)₹1.03₹5.21₹0.91₹0.54

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹8.30₹2.18₹1.70₹0.56
Current Assets₹35.24₹19.74₹8.32₹5.65
Total Assets₹43.53₹21.92₹10.03₹6.22
Current Liabilities₹19.31₹12.08₹4.14₹3.13
Net Current Asset₹15.93₹7.65₹4.19₹2.52
Non-Current Liabilities₹0.88₹2.87₹4.12₹2.12
Equity Capital₹23.35₹6.97₹1.77₹0.97
Total Equity & Liabilities₹43.53₹21.92₹10.03₹6.22
* All values are in INR Crore
Qty
Bid
8400
314.2
400
309.55
400
309
400
303
400
302
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 10000
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
65.51
Neutral
ATR (14)
6.23
Neutral
STOCH(9,6)
47.81
Neutral
STOCH RSI (14)
52.36
Neutral
ADX(9)
51.28
Bearish
UO(9)
66.5
Neutral
ROC(12)
14.69
Bullish
WillR(14)
-29.88
Neutral
Period
Simple value
Exponential vaue
5D
314.5
310.71
10D
305.51
304.58
20D
288.52
293.01
50D
263.78
265.96
100D
223.55
232.05
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
Aptus Pharma Limited Share Price
Aptus Pharma Limited
Pharmaceuticals
Add Stock
Add Another

Aptus Pharma Limited Share Price FAQs